Neuromodulation for treatment-resistant depression
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Treatment-resistant depression affects at least 1-3% of the US population. This article reviews the current state of focal neuromodulation therapies for treatment-resistant depression, focusing on those treatments published clinical data. These include transcranial magnetic stimulation, transcranial direct current stimulation, magnetic seizure therapy, vagus nerve stimulation, direct cortical stimulation, and deep brain stimulation among others. Of these, only two (transcranial magnetic stimulation and vagus nerve stimulation) currently have US Food and Drug Administration approval for the treatment of depression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643
Pascual-Leone, A., Rubio, B., Pallardó, F., & Catalá, M. D. (1996) · The Lancet · doi:10.1016/s0140-6736(96)01219-6 · Cited by 1,229
Mayberg, H. S. (2003) · British Medical Bulletin · doi:10.1093/bmb/65.1.193 · Cited by 1,166 · cited 1×
“The rationale for neuromodulation for depression is based on a neural network theory that posits a specific set of structurally and functionally connected brain regions that work together to maintain normal mood regulation [13,14].”
BackgroundSelf-citationGeorge, M. S., Lisanby, S. H., Avery, D., McDonald, W. M., Durkalski, V., Pavlicova, M., Anderson, B., Nahas, Z., Bulow, P., Zarkowski, P., et al. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.46 · Cited by 1,092 · cited 1×
“Transcranial magnetic stimulation has been studied as a treatment for depression for nearly 20 years, and a number of meta-analyses and two large sham-controlled trials have confirmed that transcranial magnetic stimulation is associated with statistically significant antidepressant effects [16,17,19-24].”
Self-citationDeep Brain Stimulation to Reward Circuitry Alleviates Anhedonia in Refractory Major Depression
Schlaepfer, T. E., Cohen, M. X., Frick, C., Kosel, M., Brodesser, D., Axmacher, N., Joe, A. Y., Kreft, M., Lenartz, D., & Sturm, V. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301408 · Cited by 1,027 · cited 1×
“(the inability to feel pleasure) as a symptom of depression and the role of the nucleus accumbens in reward processing [125].”
Daily repetitive transcranial magnetic stimulation (rTMS) improves mood in depression
George, M. S., Wassermann, E. M., Williams, W. A., Callahan, A., Ketter, T. A., Basser, P., Hallett, M., & Post, R. M. (1995) · NeuroReport · doi:10.1097/00001756-199510020-00008 · Cited by 954
Deep Brain Stimulation of the Ventral Capsule/Ventral Striatum for Treatment-Resistant Depression
Malone, D. A., Dougherty, D. D., Rezai, A. R., Carpenter, L. L., Friehs, G. M., Eskandar, E. N., Rauch, S. L., Rasmussen, S. A., Machado, A. G., Kubu, C. S., et al. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.08.029 · Cited by 897
Greenberg, B. D., Gabriels, L. A., Malone, D. A., Rezai, A. R., Friehs, G. M., Okun, M. S., Shapira, N. A., Foote, K. D., Cosyns, P. R., Kubu, C. S., et al. (2010) · Molecular Psychiatry · doi:10.1038/mp.2008.55 · Cited by 867
Bewernick, B. H., Hurlemann, R., Matusch, A., Kayser, S., Grubert, C., Hadrysiewicz, B., Axmacher, N., Lemke, M., Cooper-Mahkorn, D., Cohen, M. X., et al. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.013 · Cited by 865 · cited 1×
“Small trials have shown similar efficacy for deep brain stimulation of the ventral anterior internal capsule and ventral striatum and nucleus accumbens for treatmentresistant depression [122-124].”
Sackeim, H. A., Haskett, R. F., Mulsant, B. H., Thase, M. E., Mann, J. J., Pettinati, H. M., Greenberg, R. M., Crowe, R. R., Cooper, T. B., & Prudic, J. (2001) · JAMA · doi:10.1001/jama.285.10.1299 · Cited by 686 · cited 1×
“rates around 60%, even in treatment-resistant patients [10,11].”
Sartorius, A., Kiening, K. L., Kirsch, P., von Gall, C. C., Haberkorn, U., Unterberg, A. W., Henn, F. A., & Meyer-Lindenberg, A. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.08.027 · Cited by 611
Subcallosal Cingulate Deep Brain Stimulation for Treatment-Resistant Unipolar and Bipolar Depression
Holtzheimer, P. E. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.1456 · Cited by 608
Self-citationTargeted electrode-based modulation of neural circuits for depression.
Mayberg, H. S. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38454 · Cited by 542 · cited 1×
“The largest dataset exists for subcallosal cingulate white matter deep brain stimulation with targeting based on a converging database implicating this region and its connections in the neurobiology of the antidepressant response [113].”
Self-citationTreatment of depression with transcranial direct current stimulation (tDCS): A Review
Nitsche, M. A., Boggio, P. S., Fregni, F., & Pascual-Leone, A. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.03.038 · Cited by 498
Nemeroff, C. B., Mayberg, H. S., Krahl, S. E., McNamara, J., Frazer, A., Henry, T. R., George, M. S., Charney, D. S., & Brannan, S. K. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301082 · Cited by 496 · cited 1×
“Additional justification was provided by several human and animal studies highlighting the ability of vagus nerve stimulation to alter activity in brain regions and neurotransmitter systems implicated in depression [97].”
Self-citationTranscranial Magnetic Stimulation: Applications in Neuropsychiatry
George, M. S., Lisanby, S. H., & Sackeim, H. A. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.4.300 · Cited by 496
Deep brain stimulation for treatment-resistant depression: follow-up after 3 to 6 years
Kennedy, S. H., Giacobbe, P., Rizvi, S. J., Placenza, F. M., Nishikawa, Y., Mayberg, H. S., & Lozano, A. M. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.10081187 · Cited by 481
Self-citationKellner, C. H., Knapp, R. G., Petrides, G., Rummans, T. A., Husain, M. M., Rasmussen, K., Mueller, M., Bernstein, H. J., O’Connor, K., Smith, G., et al. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.12.1337 · Cited by 471
Transcranial direct current stimulation for depression: 3-week, randomised, sham-controlled trial
Loo, C. K., Alonzo, A., Martin, D., Mitchell, P. B., Galvez, V., & Sachdev, P. (2012) · British Journal of Psychiatry · doi:10.1192/bjp.bp.111.097634 · Cited by 455 · cited 2×
“Based on a small number of openand sham-controlled studies, transcranial direct current stimulation may have antidepressant effects in depressed patients [79,82-87].”
Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes
Nahas, Z., Marangell, L. B., Husain, M. M., Rush, A. J., Sackeim, H. A., Lisanby, S. H., Martinez, J. M., & George, M. S. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0902 · Cited by 390
George, M. S., Rush, A. J., Marangell, L. B., Sackeim, H. A., Brannan, S. K., Davis, S. M., Howland, R., Kling, M. A., Moreno, F., Rittberg, B., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.07.028 · Cited by 372 · cited 1×
“A large, sham-controlled study of vagus nerve stimulation for treatment-resistant depression showed no statistically significant benefit for 10 weeks of active vagus nerve stimulation [104], though open-label response/remission rates went up with more chronic, open-label treatment [100] and were higher than those seen…”
Bewernick, B. H., Kayser, S., Sturm, V., & Schlaepfer, T. E. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.44 · Cited by 371
Lozano, A. M., Giacobbe, P., Hamani, C., Rizvi, S. J., Kennedy, S. H., Kolivakis, T. T., Debonnel, G., Sadikot, A. F., Lam, R. W., Howard, A. K., et al. (2012) · Journal of Neurosurgery · doi:10.3171/2011.10.jns102122 · Cited by 356 · cited 1×
“Remission rates with six months to several years of subcallosal cingulate stimulation are approximately 40-60% [114-120].”
Self-citationAvery, D. H., Holtzheimer, P. E., Fawaz, W., Russo, J., Neumaier, J., Dunner, D. L., Haynor, D. R., Claypoole, K. H., Wajdik, C., & Roy-Byrne, P. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.07.003 · Cited by 318
Self-citationJiménez, F., Velasco, F., Salin-Pascual, R., Hernández, J. A., Velasco, M., Criales, J. L., & Nicolini, H. (2005) · Neurosurgery · doi:10.1227/01.neu.0000170434.44335.19 · Cited by 291
Levkovitz, Y., Harel, E. V., Roth, Y., Braw, Y., Most, D., Katz, L. N., Sheer, A., Gersner, R., & Zangen, A. (2009) · Brain Stimulation · doi:10.1016/j.brs.2009.08.002 · Cited by 217
Treatment of Vascular Depression Using Repetitive Transcranial Magnetic Stimulation
Jorge, R. E., Moser, D. J., Acion, L., & Robinson, R. G. (2008) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2007.45 · Cited by 211 · cited 1×
“priate for patients who do not tolerate or cannot take adequate doses of standard antidepressant medications (opening up the possibility for benefit in specific populations such as pregnant women [41-45], children [46-51] and the medically ill and/or elderly [52-57]).”
Vagus nerve stimulation for depression: efficacy and safety in a European study
Schlaepfer, T. E., Frick, C., Zobel, A., Maier, W., Heuser, I., Bajbouj, M., O'Keane, V., Corcoran, C., Adolfsson, R., Trimble, M., et al. (2008) · Psychological Medicine · doi:10.1017/s0033291707001924 · Cited by 205 · cited 1×
“Open-label studies have shown a 30-40% antidepressant response rate (defined as a >50% decrease depression severity) and a 15-17% remission rate after 3-24 months of vagus nerve stimulation in treatment-resistant depression patients [98-103].”
Accelerated repetitive transcranial magnetic stimulation for treatment-resistant depression
Holtzheimer, P. E., McDonald, W. M., Mufti, M., Kelley, M. E., Quinn, S., Corso, G., & Epstein, C. M. (2010) · Depression and Anxiety · doi:10.1002/da.20731 · Cited by 204
Self-citationKayser, S., Bewernick, B. H., Grubert, C., Hadrysiewicz, B. L., Axmacher, N., & Schlaepfer, T. E. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2010.09.008 · Cited by 194 · cited 1×
“troconvulsive therapy [90-94].”
Eranti, S., Mogg, A., Pluck, G., Landau, S., Purvis, R., Brown, R. G., Howard, R., Knapp, M., Philpot, M., Rabe-Hesketh, S., et al. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.1.73 · Cited by 188
Two-year outcome of vagus nerve stimulation in treatment-resistant depression
Bajbouj, M., Merkl, A., Schlaepfer, T. E., Frick, C., Zobel, A., Maier, W., O'Keane, V., Corcoran, C., Adolfsson, R., Trimble, M., et al. (2010) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181db8831 · Cited by 178 · cited 1×
“Sustained response over 12-24 months may occur in 44-77% of patients [106,107].”
Magnetic Seizure Therapy Improves Mood in Refractory Major Depression
Kosel, M., Frick, C., Lisanby, S. H., Fisch, H.-U., & Schlaepfer, T. E. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300293 · Cited by 136 · cited 1×
“troconvulsive therapy [90-94].”
Anesthetic Considerations for Magnetic Seizure Therapy: A Novel Therapy for Severe Depression
White, P. F., Amos, Q., Zhang, Y., Stool, L., Husain, M. M., Thornton, L., Downing, M., McClintock, S., & Lisanby, S. H. (2006) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000221182.71648.a3 · Cited by 111
Fabre, I., Galinowski, A., Oppenheim, C., Gallarda, T., Meder, J. F., de Montigny, C., Olié, J. P., & Poirier, M. F. (2004) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1172 · Cited by 84 · cited 1×
“priate for patients who do not tolerate or cannot take adequate doses of standard antidepressant medications (opening up the possibility for benefit in specific populations such as pregnant women [41-45], children [46-51] and the medically ill and/or elderly [52-57]).”
Repetitive transcranial magnetic stimulation treats postpartum depression
Garcia, K. S., Flynn, P., Pierce, K. J., & Caudle, M. (2010) · Brain Stimulation · doi:10.1016/j.brs.2009.06.001 · Cited by 63 · cited 1×
“priate for patients who do not tolerate or cannot take adequate doses of standard antidepressant medications (opening up the possibility for benefit in specific populations such as pregnant women [41-45], children [46-51] and the medically ill and/or elderly [52-57]).”
Intermittent theta burst stimulation (iTBS) ameliorates therapy-resistant depression: A case series
Holzer, M., & Padberg, F. (2010) · Brain Stimulation · doi:10.1016/j.brs.2009.10.004 · Cited by 55 · cited 1×
“Attempts to optimize transcranial magnetic stimulation as a treatment for depression are underway and include combining high- with low-frequency treatments [63-68], developing “deep” transcranial magnetic stimulation systems that can stimulate structures below superficial cortex [69-73] and developing novel dosing str…”
Cited by
Chung, S. W., Hoy, K. E., & Fitzgerald, P. B. (2015) · Depression and Anxiety · doi:10.1002/da.22335 · Cited by 252
Individual-specific functional connectivity of the amygdala: A substrate for precision psychiatry
Sylvester, C. M., Yu, Q., Srivastava, A. B., Marek, S., Zheng, A., Alexopoulos, D., Smyser, C. D., Shimony, J. S., Ortega, M., Dierker, D. L., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1910842117 · Cited by 139
The antidepressant mechanism of action of vagus nerve stimulation: Evidence from preclinical studies
Grimonprez, A., Raedt, R., Baeken, C., Boon, P., & Vonck, K. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.06.019 · Cited by 81
van Belkum, S. M., Bosker, F. J., Kortekaas, R., Beersma, D. G. M., & Schoevers, R. A. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.07.006 · Cited by 29
Metadata
- Authors
- Holtzheimer, P. E., & Mayberg, H. S.
- Venue
- F1000 Medicine Reports
- Publisher
- Faculty Opinions Ltd
- Published
- 2012-11-01
- Volume
- 4
- Pages
- 22-22
- ISSN
- 1757-5931 (ISSN-L)
- OpenAlex
- W2112437161
- Cited by
- 52
- References
- 37
- FWCI
- 2.67
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.